DF
IART icon

Dunhill Financial’s Integra LifeSciences IART Stock Holding History

Dunhill Financial’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13 Hold
1
– – ﹤0.01% 1809
2025
Q4 		$18 Buy
+1
New +$13 ﹤0.01% 1929

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Dunhill Financial's IART Position: Q1 2026 in Review

Dunhill Financial held its Integra LifeSciences (IART) position steady in Q1 2026 at 1 share worth $13. The position accounts for ﹤0.01% of the portfolio, ranked #1809.

Dunhill Financial first reported a position in IART in Q4 2025 and has held it in 2 quarters since. The position peaked at $18 in Q4 2025. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Dunhill Financial held 1 share of Integra LifeSciences worth $13 as of Q1 2026.
  • Dunhill Financial left its Integra LifeSciences share count unchanged in Q1 2026.
  • Integra LifeSciences made up ﹤0.01% of Dunhill Financial's portfolio in Q1 2026, its #1809 holding.
  • Dunhill Financial first reported a position in Integra LifeSciences in Q4 2025 and has held it in 2 quarters since.
  • Dunhill Financial's Integra LifeSciences position peaked at $18 in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Dunhill Financial's 13F filing for Q1 2026, filed 6 May 2026.